Problems at a Janssen over-the-counter plant in Korea have gone from unfortunate to very serious now that authorities there intend to pursue criminal charges. This tack means Kim Oak-yeon, CEO of the Johnson & Johnson ($JNJ) subsidiary in South Korea, faces up to three years in jail if convicted.

THE LIBRARY: WEBINAR

Pharma companies can employ several strategies for obtaining expedited approvals-including, in some cases, acquiring them from other companies. This webinar will feature regulatory experts from the pharma industry who can provide tips on navigating these programs. Register Today!